Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04045340
Other study ID # MIT-GO-2019
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 28, 2019
Est. completion date November 26, 2021

Study information

Verified date October 2020
Source Scientific Institute San Raffaele
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the present study is to assess the best echocardiographic parameters (GLS, GLS rate and standard echocardiographic parameters) predicting LCOS in on-pump mitral surgery.


Description:

Low cardiac output syndrome (LCOS) is a common complication in cardiac surgery after weaning from cardiopulmonary bypass (CPB) associated with high morbidity and mortality. Its prompt recognition and management may mitigate the effect of LCOS on the outcome. To date, advanced age, prolonged CPB, urgent surgery and impaired left ventricular function assessed by left ventricular ejection fraction (LVEF) are commonly considered strong predictors of postoperative LCOS. Nevertheless, LVEF has several limitations including image quality, operator experience, limited reproducibility, inter- and intra-observer discrepancy and load/volume dependency. Global Longitudinal Strain (GLS), with automated speckle-tracking echocardiography (STE) may overcome several of the LVEF limitations. In fact, while the LVEF detects changes in left ventricular chamber volume, GLS reflects myocardial longitudinal deformation due to contraction. The rate of myocardial deformation over time (expressed as 1/s) is called GLS Rate. Global Longitudinal Strain, mostly evaluated from transthoracic echocardiography (TTE), has shown lower inter- and intra-observer variability, a better reproducibility and prognostic value compared to LVEF in a generic cardiac population. In addition the results of the GLS with TTE (GLS-TTE) may not be shifted in cardiac surgery due to the effect of the general anesthesia (GA) and positive pressure ventilation. Thus, these factors should be considered when the global longitudinal strain, evaluated from transesophageal echocardiography (GLS-TEE) is used as predictor of early outcome. Amabili et al. have shown that GLS-TEE is better than LVEF in predicting LCOS in a general cardiac surgery population. Similarly Sonny et al. in patients undergoing aortic valve surgery for stenosis have reported that a GLS-TEE and GLS-TEE Rate are superior to standard echocardiographic parameters in predicting a complicated course. To the best of our knowledge, there are no studies investigating the role of intraoperative evaluation of GLS-TEE and GLS-TEE Rate as predictors of LCOS in mitral valve surgery. In this setting LVEF is not a reliable marker of cardiac function due to a systematic overestimation of the ejection fraction. Moreover these patients are at high risk of postoperative cardiac dysfunction and LCOS owing to the afterload mismatch after mitral surgery. For the reasons mentioned above, more effective predictors are advocated. In the present study we try to fill the gap. Thus, aim of present study is to assess the role of GLS-TEE, GLS-TEE Rate and standard echocardiographic parameters in predicting LCOS in on-pump mitral surgery. In doing so, the best cut-off for each echocardiographic parameter will be provided. Finally to detect the effect of the GA, the echocardiographic parameters calculated after the induction of GA will be compared with those collected preoperatively. A telephonic follow-up will be performed at 30 days and 12-months investigating mortality and rehospitalization due to heart failure.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date November 26, 2021
Est. primary completion date April 28, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients undergoing elective or urgent open mitral valve repair or mitral valve replacement over 18 years - Ability to sign informed consent - Availability of pre-CBP and after-CPB intraoperative transesophageal echocardiography which include a 4-chambers, 2-chambers and a long axis view at a minimum frame rate of 50 Hz - Good quality echocardiographic images with a optimal endocardial definition - Good quality ECG tracing Exclusion Criteria: - All patients undergoing emergent open mitral valve repair or mitral valve replacement - Unavailability of pre-CBP and after-CPB intraoperative transesophageal echocardiography which include a 4-chambers, 2-chambers and a long axis view at a minimum frame rate of 50 Hz - Poor quality echocardiographic images - ECG artefacts

Study Design


Intervention

Device:
Philips QLAB Ultrasound Quantification Software
Offline processing of intraoperative transesophageal echocardiography would be performed with Global Longitudinal Strain on apical 4 chamber, apical 2 chamber and long axis views in order to analyze left ventricle and left atrium contractility and right ventricle free wall motion

Locations

Country Name City State
Italy Scientific Institute San Raffaele Milan

Sponsors (1)

Lead Sponsor Collaborator
Scientific Institute San Raffaele

Country where clinical trial is conducted

Italy, 

References & Publications (2)

Amabili P, Benbouchta S, Roediger L, Senard M, Hubert MB, Donneau AF, Brichant JF, Hans GA. Low Cardiac Output Syndrome After Adult Cardiac Surgery: Predictive Value of Peak Systolic Global Longitudinal Strain. Anesth Analg. 2018 May;126(5):1476-1483. doi — View Citation

Sonny A, Alfirevic A, Sale S, Zimmerman NM, You J, Gillinov AM, Sessler DI, Duncan AE. Reduced Left Ventricular Global Longitudinal Strain Predicts Prolonged Hospitalization: A Cohort Analysis of Patients Having Aortic Valve Replacement Surgery. Anesth An — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Global longitudinal strain of myocardium in mitral valve surgery Offline processing of GLS, GLS Rate Intraoperative 6 hours
Primary Number of patients with low cardiac output syndrome after mitral valve surgery 30 days
Primary Global longitudinal strain threshold associated with LCOS after mitral valve surgery Intraoperative 6 hours
Secondary Effect of general anesthesia on systole and diastole Intraoperative 6 hours
Secondary All-cause mortality during the follow-up 30 days and 1years
Secondary Length of intensive care unit stay 30 days
Secondary Length of hospital stay 30 days
Secondary 30-day or in hospital mortality 30 days
Secondary Duration of post-operative mechanical ventilation 30 days
Secondary Post-operative rate of acute kidney injury 30 days
Secondary Post-operative rate of hepatic dysfunction 30 days
Secondary Readmission rate in intensive care 30 days
See also
  Status Clinical Trial Phase
Completed NCT03283722 - PRESERVE-MITRAL Post-Market Registry
Not yet recruiting NCT06167213 - ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral N/A
Recruiting NCT06001489 - The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy N/A
Recruiting NCT06025149 - The Study on the Use of "UniLine" Bioprosthesis in the Treatment of Isolated Aortic and Mitral Valve Diseases
Completed NCT05193760 - Robustness Check of Placement and Measurement Algorithms for Blood Flow Measurement on Common Carotid Artery
Completed NCT05836558 - Are the Results of Minimally Invasive Mitral Valve Repair Still Satisfactory When Looked at Very Long-term?
Recruiting NCT05531253 - Respired Gases in Patients Post Cardiac Surgery
Active, not recruiting NCT04950192 - Philips Intracardiac Echocardiography (ICE) Clinical Registry
Recruiting NCT02925819 - Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery
Completed NCT03438825 - PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients
Completed NCT02000544 - Clinical Evaluation of a Modular Extracorporeal Circulation Circuit N/A
Recruiting NCT03574311 - Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery Phase 4
Recruiting NCT06153563 - Evaluation of the Elasticity of the Mitral Valve
Active, not recruiting NCT03539458 - Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification N/A
Recruiting NCT05898230 - Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
Withdrawn NCT01849757 - Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5% N/A
Active, not recruiting NCT04147884 - A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation N/A
Completed NCT02097420 - HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve N/A
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Recruiting NCT04954404 - Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients With Mitral Valve Disease (TORCH-M) N/A